Iconovo deal aims to identify the deal product properties concerning particle size, stability, and device compatibility.

Rubicon Research plans Rs ₹500 crore IPO for growth, acquisitions, and loan repayment, with strong US market presence.

Giving up nicotine can be a brutal experience that can include everything from physical symptoms, such as headache and nausea ...

For all of you who are into herbal inhalers that are not just functional but cute, we have a whole list of options to choose ...

Iconovo AB, a developer of inhalable drugs based on proprietary inhalers and dry powder formulations, and Lonza, a healthcare ...

China has said that it is in close communication with WHO. In India, two fresh cases were reported in Gujarat on Saturday, ...

The Food and Drug Administration’s (FDA or Agency) final rule on Additional Conditions for Nonprescription Use (ACNU) paves the way for some ...

HMPV outbreaks are spreading globally. Find out how to recognize symptoms, prevent infection, and protect vulnerable groups ...

This past Fall, when visiting Lima, Peru, I had the opportunity to go swimming with sea lions in the South Pacific Ocean. It ...

By Phoenix Tso This article was first published by the nonprofit newsroom LA Public Press on Jan. 14, and is republished here ...

Impacting millions of children in the U.S. alone, asthma can be particularly problematic to diagnose with specificity — ...